Stifel Reiterates Buy on Alkermes, Raises Price Target to $63

Benzinga Newsdesk www.benzinga.com Positive 72.4%

Neg 0% Neu 0% Pos 72.4%

Stifel analyst Paul Matteis reiterates Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $45 to $63.

Comments

No comments yet. Be the first!